JPRN-UMIN000051044RecruitingUnknown
Translational research study of NIVOlumab RE-adminiTration for UnResectable/recurreNt gaStric cancer - NIVO-RETURNS TR
Trial Snapshot
- Phase
- Unknown
- Status
- Recruiting
- Sponsor
- Aichi Cancer Center
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •According to the study "Prospective observational study of efficacy and safety in re-administration of nivolumab for unresectable advanced/recurrent gastric cancer"
Investigators
Similar Trials
Recruiting
Not Applicable
observational/translational study for nivolumab treatment in advanced esophageal canceresophageal cancerJPRN-UMIN000043208Hokkaido Gastrointestinal Cancer Study Group25
Recruiting
Unknown
A prospective observational study of nivolumab plus chemotherapy for advanced gastric cancer using CyberOncology (WJOG15922G)JPRN-UMIN000049928West Japan Oncology Group100
Terminated
Phase 2
IVORAD - A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer, progressing after first or second line chemotherapy.ACTRN12616000352404niversity of Sydney50
Completed
Not Applicable
Investigation of efficacy of nivolumab in patients with recurrent and refractory peripheral T cell lymphoma: Investigator initiated phase 2 clinical trial.Peripheral T cell lymphomaJPRN-UMIN000034499Cooperative study between the West Japan Hematology Study Group and Clinical Research Support Center Kyushu20
Active, not recruiting
Phase 2
W-JHS NHL02 studyPeripheral T-cell lymphoma (including extranodal NK/T-cell lymphoma)JPRN-jRCT2071210101Akashi Koichi20